Bandingkan Harga & Kinerja Sinergi Inti Plastindo Tbk. (ESIP) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Sinergi Inti Plastindo Tbk. dan Organon Pharma Indonesia Tbk.: Sinergi Inti Plastindo Tbk. diperdagangkan di Rp122 (kapitalisasi pasar 133,19 M, volume 24 jam 144,65 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Sinergi Inti Plastindo Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| ESIP | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 133,19 M | 104,4 M |
Volume | 144,65 jt | — |
Lot | 1,45 jt | — |
Perputaran | 18,6 M | — |
Harga Rata-rata | 128,61 | — |
Nilai Transaksi | 18,6 M | — |
Harga Ekuilibrium Indikatif | 122 | — |
Volume Ekuilibrium Indikatif | 17,25 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Sinergi Inti Plastindo Tbk.
PT Sinergi Inti Plastindo Tbk (the”Company”) was established based on the notarial deed No.123 dated October 12, 2001 from Dr. Irawan Soerodjo, S.H., M.Si., Notary in Jakarta. PT Tanindo Omega Pasifik is a ultimate parent entity.
Selengkapnya di halaman ESIP →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
